Global CD30 (TNFRSF8) ELISA Kit Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global CD30 (TNFRSF8) ELISA Kit Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
CD30 (TNFRSF8) ELISA Kit is an experimental tool used to measure the concentration of CD30 (also known as TNFRSF8) protein in a sample.
CD30 (TNFRSF8) ELISA Kit report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global CD30 (TNFRSF8) ELISA Kit market is projected to reach US$ 16 million in 2029, increasing from US$ 10 million in 2022, with the CAGR of 6.9% during the period of 2024 to 2029. Demand from Hospital and Research Institute are the major drivers for the industry.
CD30 is a cell membrane protein that belongs to a member of the tumor necrosis factor receptor superfamily, and it plays an important role in immune regulation and cell signal transduction. By using the CD30 ELISA kit, the CD30 protein in the sample can be captured by a specific antibody, and then its concentration can be accurately determined by measuring the color change. The application of this kit will help in-depth study of the function and regulation mechanism of CD30 in immune regulation, disease development, and biological processes related to tumors, and provide an important tool for biomedical research and clinical diagnosis.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global CD30 (TNFRSF8) ELISA Kit market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Sino Biological, Inc.
Bio-Techne
MyBiosource, Inc.
Boster Biological Technology
Assay Genie
Signalway Antibody LLC
Abbexa
RayBiotech, Inc.
Thermo Fisher Scientific (China) Co., Ltd.
Wuhan Fine Biotech Co., Ltd.
Abcam
CUSABIO
Innovative Research
Geno Technology, Inc.
Arigo Biolaboratories Corp.
LifeSpan BioSciences, Inc
Biomatik
Segment by Type
Human
Mouse
Rat
Porcine
Others
Hospital
Research Institute
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the CD30 (TNFRSF8) ELISA Kit market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of CD30 (TNFRSF8) ELISA Kit, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the CD30 (TNFRSF8) ELISA Kit industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of CD30 (TNFRSF8) ELISA Kit in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, CD30 (TNFRSF8) ELISA Kit introduction, etc. CD30 (TNFRSF8) ELISA Kit Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of CD30 (TNFRSF8) ELISA Kit market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
CD30 (TNFRSF8) ELISA Kit report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global CD30 (TNFRSF8) ELISA Kit market is projected to reach US$ 16 million in 2029, increasing from US$ 10 million in 2022, with the CAGR of 6.9% during the period of 2024 to 2029. Demand from Hospital and Research Institute are the major drivers for the industry.
CD30 is a cell membrane protein that belongs to a member of the tumor necrosis factor receptor superfamily, and it plays an important role in immune regulation and cell signal transduction. By using the CD30 ELISA kit, the CD30 protein in the sample can be captured by a specific antibody, and then its concentration can be accurately determined by measuring the color change. The application of this kit will help in-depth study of the function and regulation mechanism of CD30 in immune regulation, disease development, and biological processes related to tumors, and provide an important tool for biomedical research and clinical diagnosis.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global CD30 (TNFRSF8) ELISA Kit market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Sino Biological, Inc.
Bio-Techne
MyBiosource, Inc.
Boster Biological Technology
Assay Genie
Signalway Antibody LLC
Abbexa
RayBiotech, Inc.
Thermo Fisher Scientific (China) Co., Ltd.
Wuhan Fine Biotech Co., Ltd.
Abcam
CUSABIO
Innovative Research
Geno Technology, Inc.
Arigo Biolaboratories Corp.
LifeSpan BioSciences, Inc
Biomatik
Segment by Type
Human
Mouse
Rat
Porcine
Others
Segment by Application
Hospital
Research Institute
Others
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the CD30 (TNFRSF8) ELISA Kit market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of CD30 (TNFRSF8) ELISA Kit, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the CD30 (TNFRSF8) ELISA Kit industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of CD30 (TNFRSF8) ELISA Kit in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, CD30 (TNFRSF8) ELISA Kit introduction, etc. CD30 (TNFRSF8) ELISA Kit Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of CD30 (TNFRSF8) ELISA Kit market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices